MiMedx Group, Inc.

Total Valuation

MiMedx Group, Inc. carries a market capitalization of 537.69M, placing it among publicly traded companies globally. Its enterprise value stands at 442.75M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

MiMedx Group, Inc. currently has 148.93M shares outstanding.

Valuation Ratios

MiMedx Group, Inc. trades at a trailing price-to-earnings ratio of 19.05. The price-to-sales ratio is 1.50, and the price-to-book ratio stands at -10.96.

Enterprise Valuation

On an enterprise value basis, MiMedx Group, Inc. trades at an EV/EBITDA multiple of 8.37 and an EV/FCF ratio of 5.84. The EV/Sales ratio of 1.14 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 11.18 provides insight into valuation relative to core operating earnings.

Financial Position

MiMedx Group, Inc. maintains a current ratio of 5.39, meaning it holds 5.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 7.24, indicating elevated leverage, while an interest coverage ratio of 131.55 demonstrates strong ability to service its debt obligations.

Financial Efficiency

Taxes

Over the trailing twelve months, MiMedx Group, Inc. has paid 11.62M in income taxes, reflecting an effective tax rate of 27.46.

Stock Price Statistics

MiMedx Group, Inc.'s stock has declined approximately -44.29012% over the past 52 weeks. The 50-day moving average sits at 3.67, while the 200-day moving average is 5.69.

Income Statement

Over the trailing twelve months, MiMedx Group, Inc. generated 389.42M in revenue and converted that into 30.70M in net income, yielding earnings per share of 0.21. EBITDA reached 52.88M, while operating income came in at 39.59M.

Balance Sheet

MiMedx Group, Inc. holds 159.77M in cash and equivalents against 17.59M in total debt, resulting in a net debt position of -142.18M. Total book value stands at -53.39M, with working capital of 195.78M providing operational flexibility.

Cash Flow

MiMedx Group, Inc. produced 70.58M in operating cash flow over the past twelve months. After subtracting -4.95M in capital expenditures, free cash flow totaled 65.63M - equivalent to 0.44 per share.

Margins

MiMedx Group, Inc. operates with a gross margin of 81.04, reflecting its pricing power and cost economics. The operating margin of 10.17 and net profit margin of 7.88 provide insight into operational efficiency.

Dividends & Yields

Stock Splits

MiMedx Group, Inc.'s most recent stock split took place on April 2, 2008 with a 2000:647 split ratio.

Scores

MiMedx Group, Inc. posts an Altman Z-Score of 7.80, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.